Today, Samsung revealed that the Food and Drug Administration had given the 

go-ahead for the upcoming irregular heart rhythm notification feature for its 

Galaxy Watches. This will first be available on its upcoming Galaxy Watch 6 and be

designed to function with its FDA-cleared EKG capability.Compared to the EKG spot-checks Apple debuted with the Series 

4 in 2018, it functions more similarly to Fitbit's passive AFib monitoring feature that was 

introduced last year. These irregular heart rhythm messages don't need the user to 

changed names. Here's where to look for the app. For quicker access, you may also